AOD-9604 dosage for fat loss typically ranges from 200 mcg to 500 mcg per day, split into one or two injections, and cycles usually last 8 to 12 weeks. Canadian researchers studying this peptide fragment of human growth hormone (hGH) will find that it targets fat metabolism without the insulin resistance or growth effects of full hGH. This guide covers dosing protocols, cycle structure, and practical sourcing considerations for researchers in Canada.
What is AOD-9604 and How Does It Work?
AOD-9604 is a modified fragment of the human growth hormone molecule, specifically amino acids 177-191. It mimics the fat-burning region of hGH while avoiding the growth-promoting and blood sugar effects. The peptide stimulates lipolysis, the breakdown of stored fat, and inhibits lipogenesis, the creation of new fat. It does this by upregulating beta-3 adrenergic receptors on fat cells, making them more responsive to fat-releasing signals. Unlike full hGH, AOD-9604 does not raise IGF-1 levels or cause insulin resistance, which makes it a safer option for metabolic research. For researchers exploring fat loss mechanisms, AOD-9604 offers a targeted tool without the systemic side effects of growth hormone.
Standard AOD-9604 Dosage for Fat Loss
The most common AOD-9604 dosage for fat loss in research is 250 mcg to 300 mcg per day. Some protocols use a single morning injection, while others split the dose into two injections, one in the morning and one in the afternoon. A typical starting dose is 200 mcg once daily, with the option to increase to 300 mcg if no adverse effects are observed. The peptide is usually administered subcutaneously, often in the abdominal area, to maximize local fat-reducing effects. Researchers should note that AOD-9604 has a short half-life, so splitting the dose may maintain more consistent blood levels. However, many studies use a single daily dose with good results. The maximum studied dose is 500 mcg per day, but this is less common and may increase the risk of side effects like mild injection site reactions.
AOD-9604 Cycle Length and Timing
An AOD-9604 cycle for fat loss typically runs 8 to 12 weeks. This duration allows enough time for the peptide to influence fat metabolism without desensitizing receptors. Some researchers extend cycles to 16 weeks, but longer cycles require a break of at least 4 weeks to reset receptor sensitivity. The peptide is often used in the morning on an empty stomach to mimic the natural fasting state, which enhances lipolysis. If splitting doses, the second injection is taken in the late afternoon, at least 2 hours after a meal. Consistency is key: daily administration without missing days yields the best results. Researchers should document changes in body composition, such as waist circumference or skinfold measurements, to assess efficacy. Unlike GLP-1 agonists like semaglutide, AOD-9604 does not suppress appetite, so it works best alongside a calorie-controlled diet and exercise.
Reconstituting and Storing AOD-9604
AOD-9604 typically comes as a lyophilized powder in vials of 2 mg or 5 mg. To reconstitute, add bacteriostatic water to the vial. For a 2 mg vial, adding 2 mL of bacteriostatic water yields a concentration of 1000 mcg per mL. For a 5 mg vial, adding 2 mL yields 2500 mcg per mL. Always use an insulin syringe for accurate measurement. Gently swirl the vial to dissolve the powder; do not shake, as this can damage the peptide. Store reconstituted AOD-9604 in the refrigerator at 2-8°C. It remains stable for about 30 days. Unreconstituted vials can be stored in the freezer for longer periods. Researchers should always follow sterile procedures to avoid contamination.
Expected Results and Timeline
Researchers studying AOD-9604 for fat loss typically observe gradual changes over the cycle. In the first 2 weeks, there may be no visible difference, but some report a slight increase in energy or a feeling of "leanness." By weeks 4 to 6, measurable reductions in waist circumference and body fat percentage often appear. The peptide works best on stubborn fat areas like the abdomen and thighs. Results are more pronounced when combined with a caloric deficit and regular exercise. Unlike stimulant-based fat burners, AOD-9604 does not cause jitters or heart rate increases. It is a slow, steady process that mimics the body's natural fat-burning pathways. Researchers should not expect dramatic weight loss; instead, the peptide promotes a gradual shift in body composition. For those interested in muscle preservation during fat loss, combining AOD-9604 with other peptides like CJC-1295 and Ipamorelin for muscle retention may be beneficial.
Safety and Side Effects in Research
AOD-9604 has a strong safety profile in clinical studies. It has been tested in human trials for obesity and showed no significant adverse effects at doses up to 500 mcg per day. The most common side effect is mild redness or irritation at the injection site. Some researchers report temporary water retention or mild headaches in the first few days. Because AOD-9604 does not affect insulin or IGF-1, it does not cause the blood sugar issues associated with full hGH. It also does not stimulate cell proliferation, reducing any theoretical cancer risk. However, researchers should still monitor subjects for any unexpected reactions. Pregnant or nursing subjects should not be used. As with all research peptides, AOD-9604 is not approved for human consumption and is intended for laboratory research only.
Combining AOD-9604 with Other Peptides
For enhanced fat loss and muscle preservation, researchers often stack AOD-9604 with other peptides. A popular stack is AOD-9604 with Ipamorelin and CJC-1295, which boosts growth hormone release and supports lean muscle mass. This combination can accelerate fat loss while preventing muscle breakdown during a calorie deficit. Another common stack is AOD-9604 with CJC-1295 for muscle retention during aggressive cuts. For researchers focused solely on fat loss, AOD-9604 can be used with a GLP-1 agonist like semaglutide, though this requires careful monitoring of blood sugar and appetite. Always start with one peptide at a time to assess individual response before stacking.
AOD-9604 vs. Other Fat Loss Peptides
Compared to other fat loss peptides, AOD-9604 offers a unique mechanism. HGH Fragment 176-191, a similar peptide, also targets fat cells but may be less stable. MOTS-c improves metabolic function and insulin sensitivity, making it a good complement. Tesamorelin reduces visceral fat but requires a prescription in many countries. AOD-9604 stands out for its specificity and safety. It does not require cycling off to prevent receptor downregulation as strictly as some GHRPs. For researchers in Canada, AOD-9604 is a popular choice because it is not a controlled substance and can be legally purchased for research purposes. When considering options for fat loss research, AOD-9604 provides a targeted approach without the systemic effects of other compounds. For those exploring muscle preservation alongside fat loss, CJC-1295 with Ipamorelin for preventing muscle loss is another avenue to investigate.
Sourcing AOD-9604 in Canada
Canadian researchers can buy AOD-9604 from specialized peptide suppliers that ship domestically. When purchasing, look for vendors that provide third-party purity testing, typically by HPLC or mass spectrometry. AOD-9604 is sold in 2 mg or 5 mg vials, with prices ranging from $30 to $60 CAD per 2 mg vial. Always verify the supplier's reputation through researcher forums and reviews. Because AOD-9604 is a research chemical, it is not for human use and should be handled in a laboratory setting. Ensure the product is shipped with proper packaging to maintain cold chain if reconstituted. Some suppliers offer discreet shipping within Canada, which can be important for researchers concerned about privacy. Remember that importing peptides from outside Canada may involve customs delays or seizure, so domestic sources are preferable.
Practical Tips for Researchers
To maximize the value of an AOD-9604 research project, follow these guidelines. First, establish a baseline with body measurements and photos. Track progress weekly under consistent conditions. Use a calorie-tracking method to ensure a deficit of 300-500 calories per day. Incorporate both resistance training and cardio for optimal fat loss. Stay hydrated, as lipolysis requires water. Avoid alcohol, which can impair fat metabolism. If using other peptides, space injections at least 30 minutes apart. Rotate injection sites to prevent tissue irritation. Finally, keep a detailed log of dosages, timing, and observations to contribute to the broader research community. For researchers interested in tendon recovery alongside fat loss, BPC-157 dosage for tendon recovery may offer complementary benefits.
Frequently Asked Questions
Many researchers have questions about AOD-9604 protocols. Here are answers to common queries. Can AOD-9604 be used long-term? While cycles up to 16 weeks have been studied, it is best to cycle off for at least 4 weeks to maintain effectiveness. Does AOD-9604 require refrigeration? Yes, once reconstituted, it must be kept cold. Is AOD-9604 legal in Canada? It is legal for research purposes but not approved for human use. Can it be combined with other peptides? Yes, but start with one at a time to gauge response. What is the best time to inject? Morning on an empty stomach is ideal, with a second dose in the afternoon if splitting. How soon are results visible? Most
The author does not endorse vendors, sellers, or sources of any peptide discussed in this article.